Prognostic impact of the BRAF V600E mutation in patients with MSI-high metastatic colorectal cancer treated with immune checkpoint inhibitors
European Journal of Cancer · 2025-09 · 227 · 115645
DOI: 10.1016/j.ejca.2025.115645 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift European Journal of Cancer, 2025-09. Verfasst von Claire Gallois und 23 weiteren Autor:innen. Beteiligte Einrichtung: Paris-Cité University, Department of Gastroenterology and Digestive Oncology, Georges Pompidou European Hospital, SIRIC CARPEM, Paris, France. Electr…. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins B-raf, Immune Checkpoint Inhibitors, Colorectal Neoplasms, Microsatellite Instability. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Ministero della Salute.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Paris-Cité University, Department of Gastroenterology and Digestive Oncology, Georges Pompidou European Hospital, SIRIC CARPEM, Paris, France. Electronic address: claire.gallois@aphp.fr.
- Paris-Cité University, Department of Gastroenterology and Digestive Oncology, Georges Pompidou European Hospital, SIRIC CARPEM, Paris, France; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumo…
- Department of Medical Oncology, Veneto Institute of Oncology (IOV) - IRCCS, Padua, Italy.
- Digestive Oncology Department, Rangueil Hospital, University Hospital of Toulouse, Toulouse, France.
- Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
- Division of Oncology and of Gastroenterology and Hepatology, Mayo Clinic and Mayo Comprehensive Cancer Center, Rochester, MN, USA.
Förderung
- Ministero della Salute
Zitieren
APA
Gallois, C., Ambrosini, M., Lonardi, S., Alouani, E., Guimbaud, R., Overman, M. J., Sinicrope, F., Mazard, T., Decraecker, M., Ros, J., Elez, E., Pernot, S., Cremolini, C., Boilève, A., Parent, P., Jayachandran, P., Dutherage, M., Mercier, M., Flecchia, C., …, & Tougeron, D. (2025). Prognostic impact of the BRAF V600E mutation in patients with MSI-high metastatic colorectal cancer treated with immune checkpoint inhibitors. European Journal of Cancer, 227, 115645. https://doi.org/10.1016/j.ejca.2025.115645
Vancouver
Gallois C, Ambrosini M, Lonardi S, Alouani E, Guimbaud R, Overman MJ, et al. Prognostic impact of the BRAF V600E mutation in patients with MSI-high metastatic colorectal cancer treated with immune checkpoint inhibitors. European Journal of Cancer. 2025;227:115645. doi:10.1016/j.ejca.2025.115645
BibTeX
@article{Gallois2025,
author = {Gallois, Claire and Ambrosini, Margherita and Lonardi, Sara and Alouani, Emily and Guimbaud, Rosine and Overman, Michael J and Sinicrope, Frank and Mazard, Thibault and Decraecker, Marie and Ros, Javier and Elez, Elena and Pernot, Simon and Cremolini, Chiara and Boilève, Alice and Parent, Pauline and Jayachandran, Priya and Dutherage, Marie and Mercier, Mathilde and Flecchia, Clémence and Fakih, Marwan and Sclafani, Francesco and Pietrantonio, Filippo and Taieb, Julien and Tougeron, David},
title = {Prognostic impact of the BRAF V600E mutation in patients with MSI-high metastatic colorectal cancer treated with immune checkpoint inhibitors},
journal = {European Journal of Cancer},
year = {2025},
volume = {227},
pages = {115645},
doi = {10.1016/j.ejca.2025.115645}
}
EUVIMED